Cryo Cell International (CCEL) Shares Outstanding (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Shares Outstanding data on file, last reported at $8.1 million in Q1 2026.

• Quarterly Shares Outstanding fell 45.76% year-over-year to $8.1 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $8.1 million (down 45.76% YoY) and the FY2025 annual result came in at $14.9 million, changed 0.19% from the prior year.
• Shares Outstanding slipped to $8.1 million in Q1 2026 per CCEL's latest filing, from $14.9 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $14.9 million in Q3 2025 and bottomed at $14.7 million in Q1 2022.
• The 5-year median for Shares Outstanding is $14.8 million (2023), against an average of $14.8 million.
• The widest annual swing landed in 2022, when Shares Outstanding climbed 7.44%; it then plunged 45.76% in 2026.
• Tracing CCEL's Shares Outstanding over 5 years: stood at $14.8 million in 2022, then advanced by 0.01% to $14.8 million in 2023, then rose by 0.0% to $14.8 million in 2024, then grew by 0.19% to $14.9 million in 2025, then tumbled by 45.86% to $8.1 million in 2026.
• Per Business Quant, the three latest CCEL Shares Outstanding figures stand at $8.1 million (Q1 2026), $14.9 million (Q4 2025), and $14.9 million (Q3 2025).

Peer Comparison